Metabolic Disorders - High Point Clinical Trial Center
 

Metabolic Disorders

PATIENT ACCESS

Metabolic Disease

  • Hyperlipidemia
  • Dyslipidemia (cholesterol and triglycerides)
  • Hypertension

Diabetes

  • T1DM and T2DM (including metformin)
  • T1DM/T2DM + Nephropathy or Fatty Liver

Obesity

  • Obesity with BMI of 30 to >40
  • Stratified by sex, age, and gender

CLINIC CAPABILITIES

Our patient-centric facility with 24/7 medical oversight provides the perfect location for conducting studies on metabolic disorders.

 

50+ Phase I to III Studies

  • Efficacy and Long-term safety
  • BA/BE, PK/PD and POC
  • SAD/MAD and Adaptive Designs
  • Clamping techniques
  • Ability to support multiple ROAs (oral, sub-lingual, IV, nasal, subcutaneous, intramuscular, parenteral, inhalation, infusion)
  • OGTT: Oral Glucose Tolerance Test with indirect calorimetry
  • Biomarker testing with Pacific Biomarkers and other providers

CASE STUDIES

Come and join us at one of our upcoming events!

Successful enrollment of 100+ T2DM Patients for a 21-day inpatient stay

Successful enrollment of 60 Obese Subjects in a Phase 1 Study with Moderate Dyslipidemia

Bioavailability, Tolerability and Safety Study

Phase 1 comparability Study to assess subcutaneous PD and PK

Phase 1 Single/Multiple Dose Study to Assess Safety, Tolerability and Pharmacokinetics in Subjects with Type 2 Diabetes Mellitus

Phase 3 LDL-C lowering evaluation in Patients with Primary Hyperlipidemia